BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16966567)

  • 1. Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
    Sprenger A; Rambold H; Sander T; Marti S; Weber K; Straumann D; Helmchen C
    Neurology; 2006 Sep; 67(5):905-7. PubMed ID: 16966567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
    Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
    Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
    Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
    Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
    Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
    J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus.
    Marti S; Palla A; Straumann D
    Ann Neurol; 2002 Dec; 52(6):712-21. PubMed ID: 12447924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
    Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
    J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
    Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
    Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
    Helmchen C; Sprenger A; Rambold H; Sander T; Kömpf D; Straumann D
    Neurology; 2004 Aug; 63(4):752-3. PubMed ID: 15326263
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
    Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
    J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
    Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
    Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
    Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
    Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling drug modulation of nystagmus.
    Glasauer S; Rössert C
    Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 3-4 diaminopyridine (DAP) in motor neuron diseases.
    Bertorini TE; Rashed H; Zeno M; Tolley EA; Igarashi M; Li YD
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):129-37. PubMed ID: 21321491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human vertical optokinetic nystagmus and after-response, and their dependence upon head orientation with respect to gravity.
    Wei G; Lafortune SH; Ireland DJ; Jell RM
    J Vestib Res; 1994; 4(1):37-47. PubMed ID: 8186862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
    Helmchen C; Gottschalk S; Sander T; Trillenberg P; Rambold H; Sprenger A
    J Neurol; 2007 Aug; 254(8):1126-8. PubMed ID: 17410325
    [No Abstract]   [Full Text] [Related]  

  • 16. No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
    Lorenz D; Hagen K; Ufer M; Cascorbi I; Deuschl G; Volkmann J
    Neurology; 2006 Jun; 66(11):1753-5. PubMed ID: 16769957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia--a comment.
    Strupp M; Kalla R; Freilinger T; Dichgans M; Brandt T
    Brain; 2005 Jun; 128(Pt 6):E32; author reply E33. PubMed ID: 15900025
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of gravity on vertical eye position.
    Pierrot-Deseilligny C
    Ann N Y Acad Sci; 2009 May; 1164():155-65. PubMed ID: 19645894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upbeat about downbeat nystagmus.
    Halmagyi GM; Leigh RJ
    Neurology; 2004 Aug; 63(4):606-7. PubMed ID: 15326227
    [No Abstract]   [Full Text] [Related]  

  • 20. Eye hyperdeviation in mouse cerebellar mutants is comparable to the gravity-dependent component of human downbeat nystagmus.
    Stahl JS; Oommen BS
    Prog Brain Res; 2008; 171():503-8. PubMed ID: 18718346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.